Lung Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Lung Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) [Phase 3]
A Phase 3 clinical trial (Chemo-IO ACCIO) is evaluating adding an immunotherapy agent to standard chemotherapy for non-small cell lung cance…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer [Phase 2]
This Phase 2 clinical trial evaluates stereotactic body radiation therapy with or without nivolumab for patients with Stage I-IIA or recurre…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating adding berzosertib to standard carboplatin/gemcitabine and to pembrolizumab for patients with advan…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations [Phase 1, Phase 2]
Phase 1/2 trial of TER-2013 in solid tumors harboring AKT/PI3K/PTEN alterations is currently recruiting to assess safety and preliminary eff…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer [Phase 1]
Phase I clinical trial evaluating C-CAR031, a GPC3-targeted CAR T-cell therapy, in participants with advanced or metastatic squamous cell lu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors [Phase 1]
Phase 1 study of palbociclib in combination with gedatolisib in patients with advanced solid tumors, including lung squamous cell carcinoma,…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC
A clinical trial to evaluate whether peripheral blood ETASTs can predict the efficacy of chemoimmunotherapy in non-small cell lung cancer. T…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: JMT106 Injection in the Treatment of Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating JMT106 injection for advanced solid tumors, including lung squamous cell carcinoma and hepatocellular carcinoma, is…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer [Phase 2]
Phase II clinical trial evaluating low-dose radiation with SBRT plus Sintilimab and chemotherapy versus Sintilimab and chemotherapy in local…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC [Phase 1]
Phase 1 study evaluating the safety and feasibility of combining pirfenidone with standard first-line chemotherapy in advanced non-small cel…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma
This clinical trial update discusses predictive biomarkers for response to PD-1 inhibitors in squamous cell carcinomas, spanning esophageal,…
-
CLINICAL_TRIALS withdrawal · 2025-08-05Clinical Trial Update: STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1 [Phase 2]
This Phase 2, single-arm trial evaluating tiragolumab plus ivonescimab for lung squamous cell carcinoma in patients who progressed on platin…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Alaunos Therapeutics reports long-term follow-up data from subjects treated with autologous T cells engineered with a Sleeping Beauty system…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT [Phase 2]
A Phase 2 clinical trial is evaluating whole-body HER3 quantification using radiolabeled patritumab deruxtecan (HER3-DXd) PET/CT in non-smal…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma
A clinical trial evaluating the therapeutic effect of immunotherapy in advanced lung squamous cell carcinoma is currently enrolling by invit…
-
CLINICAL_TRIALS withdrawal · 2024-09-03Clinical Trial Update: SCION: SABR and Checkpoint Inhibition of NSCLC [Phase 2]
A Phase 2 trial (SCION) evaluating stereotactic ablative radiotherapy (SABR) with checkpoint inhibition for non-small cell lung cancer has b…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: BAI-BACE for Advanced Lung Squamous Cell Carcinoma [NA]
Clinical trial update for BAI-BACE in advanced lung squamous cell carcinoma; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: Mechanism Study to Investigate Difference in Efficacy of Neoadjuvant Chemoimmunotherapy in Lung Squamous Cell Carcinoma
This study investigates mechanisms behind differing efficacy of neoadjuvant chemoimmunotherapy in lung squamous cell carcinoma, focusing on …
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma [Phase 2]
This is a Phase 2 clinical trial evaluating neoadjuvant EGFR-targeted therapy in patients with resectable EGFR-mutated lung squamous cell ca…
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: SHR-1701 Combined With Fluzoparib in Lung Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating SHR-1701 in combination with Fluzoparib for non-small cell lung cancer (lung squamous cell carcinoma).
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy [Phase 2]
Phase 2 clinical trial update evaluating pevonedistat with carboplatin and paclitaxel in advanced non-small cell lung cancer patients previo…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma [Phase 2]
A Phase 2 trial evaluating radiation and gene therapy before nivolumab in metastatic non-small cell lung cancer and uveal melanoma was termi…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: A Study of Endostar Combined With Chemotherapy and Immunotherapy in Lung Squamous Cell Carcinom [Phase 4]
Phase 4 trial update exploring Endostar with chemotherapy and immunotherapy in lung squamous cell carcinoma is reported but current status i…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer [Phase 2]
Phase 2 trial update for Sapanisertib in patients with stage IV or recurrent lung squamous cell carcinoma shows completed status and posted …
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating tislelizumab in combination with chemotherapy as neoadjuvant therapy for stage IIIA-IIIB (N2) lung squamous cell …